Results 21 to 30 of about 813,815 (239)

YKL-40 is highly expressed in the epicardial adipose tissue of patients with atrial fibrillation and associated with atrial fibrosis

Journal of Translational Medicine, 2018
Background YKL-40 (CHI3L1) is a novel biomarker for inflammation, tissue remodeling, and fibrosis, as well as cardiovascular diseases. We investigated the association between YKL-40 expression in epicardial adipose tissue (EAT) and atrial fibrosis in ...
Qing Wang, Hua Shen, Jie Min, Yang Gao, Kai Liu, Wang Xi, Jie Yang, Liang Yin, Jibin Xu, Jian Xiao, Zhinong Wang   +10 more
doaj   +1 more source

Focal impulse and rotor modulation of atrial rotors during atrial fibrillation leads to organization of left atrial activation as reflected by waveform morphology recurrence quantification analysis and organizational index

Journal of Arrhythmia, 2020
Background Focal impulse and rotor modulation (FIRM) can cause slowing, organization, and occasionally termination of atrial fibrillation (AF), although results have been mixed.
Peter R. Liu, Daniel J. Friedman, Adam S. Barnett, Kevin P. Jackson, James P. Daubert, Jonathan P. Piccini   +5 more
doaj   +1 more source

Incidence and Predictors of Complications During Cryoballoon Pulmonary Vein Isolation for Atrial Fibrillation

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundCryoballoon pulmonary vein isolation (PVI) has emerged as an alternative to radiofrequency PVI for atrial fibrillation (AF). Data are lacking to define the rates and predictors of complications, particularly phrenic nerve injury (PNI).
Emily N. Guhl, Donald Siddoway, Evan Adelstein, Raveen Bazaz, George S. Mendenhall, Jan Nemec, Samir Saba, David Schwartzman, Andrew Voigt, Norman C. Wang, Sandeep K. Jain   +10 more
doaj   +1 more source

Covid-19 pandemic induced traumatizing medical job contents and mental health distortions of physicians working in private practices and in hospitals

Scientific Reports, 2023
The Covid-19 pandemic during its early phases posed significant psychological threats particularly for medical frontline personal. It is unclear whether the medical workforce with the passage of time has adapted to these threats or have generalized to ...
Karl-Heinz Ladwig, Hamimatunnisa Johar, Inna Miller, Seryan Atasoy, Andreas Goette   +4 more
doaj   +1 more source

Blood pressure control versus atrial fibrillation management in stroke prevention [PDF]

, 2015
Hypertension is one of the major risk factors for atrial fibrillation which in turn is the most prevalent concomitant condition in hypertensive patients. While both these pathological conditions are independent risk factors for stroke, the association of
Sada, Lidia, Savoia, Carmine, Volpe, Massimo   +2 more
core   +1 more source

Dabigatran versus warfarin in patients with atrial fibrillation.

New England Journal of Medicine, 2009
BACKGROUND Warfarin reduces the risk of stroke in patients with atrial fibrillation but increases the risk of hemorrhage and is difficult to use. Dabigatran is a new oral direct thrombin inhibitor.
S. Connolly, M. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, A. Parekh, J. Pogue, P. Reilly, E. Themeles, Jeanne Varrone, Susan Wang, M. Alings, D. Xavier, Jun Zhu, R. Diaz, B. Lewis, H. Darius, H. Diener, C. Joyner, L. Wallentin   +19 more
semanticscholar   +1 more source

Sex-related differences in risk factors, type of treatment received and outcomes in patients with atrial fibrillation and acute stroke: Results from the RAF-study (Early Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation) [PDF]

, 2016
Introduction: Atrial fibrillation is an independent risk factor of thromboembolism. Women with atrial fibrillation are at a higher overall risk for stroke compared to men with atrial fibrillation. The aim of this study was to evaluate for sex differences
Abdul-Rahim, Azmil, Acciarresi, Monica, Ageno, Walter, Agnelli, Giancarlo, Akhtar, Naveed, Alberti, Andrea, Antonenko, Kateryna, Baldi, Antonio, Barlinn, Kristian, Baronello, Mario M., Becattini, Cecilia, Bodechtel, Ulf, Bono, Giorgio, Bovi, Paolo, Carletti, Monica, Carolei, Antonio, Caso, Valeria, Chiti, Alberto, Consoli, Domenico, Cordier, Maria, Corea, Francesco, Csiba, Laszló, De Lodovici, Maria Luisa, Del Sette, Massimo, Deleu, Dirk, Denti, Licia, Doronin, Boris, D’Amore, Cataldo, D’Anna, Antonio, Falocci, Nicola, Galati, Franco, Gerber, Johannes, Gialdini, Gino, Guideri, Francesca, Ibrahim, Faisal, Imberti, Davide, Kepplinger, Jessica, Lees, Kennedy R., Lorenzini, Gianni, Marcheselli, Simona, Martini, Giuseppe, Masotti, Luca, Melikyan, Gayane, Michel, Patrik, Monaco, Serena, Mosconi, Maria G., Orlandi, Giovanni, Paciaroni, Maurizio, Padovani, Alessandro, Pallesen, Lars-Peder, Papageorgiou, Sokratis G., Pezzini, Alessandro, Pieroni, Alessio, Poli, Loris, Putaala, Jukka, Remillard, Suzette, Rigatelli, Alberto, Rueckert, Christina, Sacco, Simona, Scoditti, Umberto, Sohn, Sung-Il, Szabó6, Lilla, Tassi, Rossana, Tassinari, Tiziana, Tatlisumak, Turgut, Tiseo, Cindy, Toni, Danilo, Tsivgoulis, Georgios, Vadik, Kostantinos, Vanacker, Peter, Venti, Michele, Volodina, Vera, Zabzuni, Dorjan   +72 more
core   +1 more source

Anxiety and Depression Prevalence and Risk Factors Among Patients With Cardiovascular Diseases in Post-COVID-19 China

Frontiers in Public Health, 2022
Objective: Data are limited on the psychological disorders of patients with cardiovascular disease during the post-COVID-19 period, although mental health status is associated with morbidity and mortality.
Minglan Wu, Minglan Wu, Liying Shen, Qiqi Wang, Li Liu, Sen Lu, Jianmei Jin, Zhen Dai, Zheyue Shu   +8 more
doaj   +1 more source

Edoxaban versus warfarin in patients with atrial fibrillation.

New England Journal of Medicine, 2013
BACKGROUND Edoxaban is a direct oral factor Xa inhibitor with proven antithrombotic effects. The long-term efficacy and safety of edoxaban as compared with warfarin in patients with atrial fibrillation is not known.
R. Giugliano, C. Ruff, E. Braunwald, S. Murphy, S. Wiviott, J. Halperin, A. Waldo, M. Ezekowitz, J. Weitz, J. Špinar, W. Rużyłło, M. Ruda, Y. Koretsune, Joshua Betcher, M. Shi, L. Grip, Shirali P Patel, Indravadan Patel, J. Hanyok, M. Mercuri, E. Antman   +20 more
semanticscholar   +1 more source

Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure

Circulation, 2021
Supplemental Digital Content is available in the text. Background: In patients with heart failure and atrial fibrillation (AF), several clinical trials have reported improved outcomes, including freedom from AF recurrence, quality of life, and survival ...
D. Packer, J. Piccini, K. Monahan, H. Al-Khalidi, A. Silverstein, P. Noseworthy, J. Poole, T. Bahnson, Kerry L Lee, D. Mark   +9 more
semanticscholar   +1 more source